Cannabidiol (CBD)

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

The agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.

Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.

In the midst of an opioid epidemic, CBD may help patients experiencing opioid withdrawal symptoms find relief.

CBD is a hot topic on the internet and social media, but large percentages of posts are making therapeutic claims that are not FDA approved or backed by enough research.

Research examines how cannabidiol impacts plasma endocannabinoid when consumed along with delta-9-tetrahydrocannabinol.

With the rise of cannabidiol (CBD) use, understanding how it can impact the effect of other medications is important.

CBD therapy has had positive outcomes in other inflammatory conditions.

Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.

No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.

CBD can be used to treat a myriad of women’s health conditions, but research is still limited.

Tips to help your pharmacy stand out as a knowledgeable CBD retailer.

Encouraging outcomes in recent studies have researchers calling for more analysis of the effect of cannabinoids on sleep disorders.

Addressing patient concerns about cannabidiol can be the key to patient satisfaction.

Even “THC-free” cannabidiol products may contain trace amounts of THC.

CBD products range from gummies to tinctures to topical lotions and creams.

CBD is still a gray area for many pharmacists and health care providers.

Patients should start low, go slow, and track their own dosing and effects

Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.

Patient confidence in CBD products—and pharmacist ability to provide counsel—increased during the study.

A national survey found that patients are willing to try medical cannabis products as potential treatments of their condition. Additionally, some already use over-the-counter cannabis products.

Take a look back at the top 10 CBD news articles published on Drug Topics® this year.

Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.

A recent review expounded the effects that cannabidiol may be having on cognition in patients with epilepsy.

Investigators supplemented a slim body of existing research on CBD for pain management.

Co-principal investigators Jeff Lombardo and Keith Aqua discuss the unique patient profiles of the study, future cohorts, and FDA's response to the findings.

Pharmacists interested in driving profit through CBD can start by changing their mindset.

Selling CBD can be profitable for pharmacies, if they follow regulatory guidelines.